Bliss GVS Pharma Limited
LIC sold 21,32,071 shares of Bliss GVS Pharma in the open market, decreasing its stake from 5.11% to 2.96%.
A pharmaceutical manufacturer engaged in producing and marketing a diverse range of formulations including suppositories, pessaries, capsules, tablets, and syrups. The company operates across manufacturing, marketing, trading, and export functions, serving both domestic and international markets. Established in 1984, it has developed specialized expertise in multiple dosage forms and maintains an integrated operation across the pharmaceutical value chain to address varied healthcare requirements.
India's largest domestic institutional investor with over Rs 56 lakh crore in total AUM, of which roughly Rs 15 lakh crore sits in listed equities. Holds stakes in virtually every major listed Indian company. When LIC builds or exits a position, it moves markets. Government-owned and mandated to invest policyholder funds in Indian equities and bonds, making it the ultimate long-only, long-term India bull.